•
Jun 30, 2011

Jazz Pharmaceuticals Q2 2011 Earnings Report

Total Revenue
$64.6M
Previous year: $40.5M
+59.5%
EPS
$0.81
Previous year: $0.81
+0.0%
Gross Profit
$61.2M
Previous year: $37.7M
+62.4%
Cash and Equivalents
$102M
Previous year: $9.57M
+969.5%
Total Assets
$193M

Jazz Pharmaceuticals

Jazz Pharmaceuticals